Eli Lilly becomes the first healthcare company to reach a $1 trillion market cap, riding high on the success of its weight loss injection Zepbound and diabetes treatment Mounjaro.
TL/DR -
Former President Donald Trump claimed that low insulin prices were due to his administration, not President Joe Biden's, despite the fact that the prices have dropped under Biden's tenure. Trump's comments come as health care becomes a significant issue in the upcoming election, with Biden holding an 11-point lead over Trump on providing…